News Focus
News Focus
Post# of 257479
Next 10
Followers 843
Posts 122921
Boards Moderated 9
Alias Born 09/05/2002

Re: DewDiligence post# 245298

Tuesday, 05/02/2023 10:20:19 AM

Tuesday, May 02, 2023 10:20:19 AM

Post# of 257479
PFE reports 1Q23 results—reiterates 2023 guidance:

https://s28.q4cdn.com/781576035/files/doc_financials/2023/q1/Q1-2023-PFE-Earnings-Release.pdf

Reiterated 2023 guidance is: $3.25-3.45 of non-GAAP EPS; $67-71M of revenue including $21.5B for COVID products ($13.5B Comirnaty, $8B Paxlovid); and organic sales growth excluding COVID products of 7-9%.

1Q23 COVID sales were $7.1B ($2.9B Comirnaty, $4.1B Paxlovid).

CC slides:
https://s28.q4cdn.com/781576035/files/doc_financials/2023/q1/Q1-2023-Earnings-Charts-FINAL.pdf

Prepared CC remarks (synched with slides):
https://s28.q4cdn.com/781576035/files/doc_financials/2023/q1/Q1-2023-Earnings-Conference-Call-Prepared-Remarks-FINAL.pdf

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today